Filters

See more specimen types...

Other countries

See more countries

Results: 1 to 20 of 56 (representing 22 labs)

Tests names and labsConditionsGenes and analytesMethods

AllNeuro panel

Centogene AG - the Rare Disease Company
Germany
7861205
  • C Sequence analysis of the entire coding region

Episodic ataxia type 5

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

KCNA1, CACNA1A, CACNB4, SLC1A3. NextGeneDx. Complete sequencing by NGS

Instituto de Medicina Genomica
Spain
14
  • C Sequence analysis of the entire coding region

CACNB4. Complete sequencing

Instituto de Medicina Genomica
Spain
21
  • C Sequence analysis of the entire coding region

CACNB4 Single Gene Test

Courtagen Diagnostics Laboratory Courtagen Life Sciences
United States
11
  • C Sequence analysis of the entire coding region

Benign Epilepsies Spotlight Panel

Courtagen Diagnostics Laboratory Courtagen Life Sciences
United States
2415
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Myoclonic Seizures B Spotlight Panel

Courtagen Diagnostics Laboratory Courtagen Life Sciences
United States
3618
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Episodic ataxia panel

LifeLabs Genetics
Canada
33
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Ataxia Panel

Blueprint Genetics
Finland
2141
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Idiopathic Generalized and Focal Epilepsy Panel

Blueprint Genetics
Finland
233
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Comprehensive Epilepsy Panel

Blueprint Genetics
Finland
4194
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Ataxia, Complete Dominant Evaluation

Athena Diagnostics Inc
United States
3125
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Ataxia, Supplemental Dominant Evaluation

Athena Diagnostics Inc
United States
2216
  • C Sequence analysis of the entire coding region

Ataxia, Comprehensive Evaluation

Athena Diagnostics Inc
United States
4442
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Episodic Ataxia Evaluation

Athena Diagnostics Inc
United States
54
  • C Sequence analysis of the entire coding region

Neurogenetic Disorders - panels

Medizinisch Genetisches Zentrum München MGZ München
Germany
14597
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Epilepsy/Seizure

Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health and Science University
United States
598
  • C Sequence analysis of the entire coding region

Childhood Epilepsy

Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health and Science University
United States
347
  • C Sequence analysis of the entire coding region

Invitae Epilepsy Panel

Invitae
United States
111103
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Ataxia, autosomal dominant and X-linked Panel

CeGaT GmbH
Germany
1234
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 56

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center